跳至主要内容
临床试验/TCTR20190623001
TCTR20190623001尚未招募2 期

A COMPARATIVE STUDY ON EFFICACY AND SAFETY OF RTSABYUGS (FORMULA FROM BHUTAN) VERSUS DICLOFENAC FOR RELIEVING KNEE PAIN IN PRIMARY OSTEOARTHRITIS PATIENTS

Thammasat University0 个研究点目标入组 62 人开始时间: 2019年6月23日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Years 至 75 Years(—)
性别
All

入选标准

  • a)Both male and female, age group between 45-75years old
  • b)Body mass index (BMI) < 25 kg/m2
  • c)The symptoms of OA must have mild to moderate according to
  • the index of severity for OA of the knee.
  • d)Participants with minimum visual analog scale (VAS) score
  • e)Good communication and cooperation.
  • f)Participants should not under go any medication before 2
  • weeks of enrollment in the research.
  • g)Participants oriented to the risks and benefits of the
  • research and willing to sign the consent form.

排除标准

  • a)Participants using any topical application during
  • investigation.
  • b)Patient undergone lower extremity surgery in the past 6
  • c)Conditions of erythema, edema and with open wound on the
  • d)Women with pregnancy or breast feeding.
  • e)Participants having allergic to herbs such as; Ccurcuma
  • longa, Myristica fragrans, Carum curvi, Delphnium
  • brununium, Catleya spicata and Plai.
  • f)If the subject plan to admit for surgery or move to other
  • places during the study.

研究者

相似试验

A COMPARATIVE STUDY ON EFFICACY AND SAFETY OF... | 临床试验